Answer
Renoxitin (cefoxitin sodium) product information highlights potentiation of oral anticoagulant activity and uncontrolled INR during antibiotic therapy, with infection or inflammation, age and general condition as risk factors, while noting uncertainty over whether illness or treatment causes the INR disturbance.
Sources for this answer
- Renoxitin 1g and 2g Powder for Solution for Injection or InfusionRenascience Pharma Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked